Rhythm Pharmaceuticals, Inc. (RYTM)
104.85
-0.57
(-0.54%)
USD |
NASDAQ |
Sep 03, 16:00
104.85
0.00 (0.00%)
After-Hours: 17:35
Rhythm Pharmaceuticals Net Income (TTM) : -205.35M for June 30, 2026
Net Income (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Net Income (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | -205.35M |
| March 31, 2026 | -202.68M |
| December 31, 2025 | -196.54M |
| September 30, 2025 | -192.33M |
| June 30, 2025 | -183.06M |
| March 31, 2025 | -168.69M |
| December 31, 2024 | -260.57M |
| September 30, 2024 | -258.90M |
| June 30, 2024 | -259.42M |
| March 31, 2024 | -273.86M |
| December 31, 2023 | -184.67M |
| September 30, 2023 | -185.54M |
| June 30, 2023 | -182.24M |
| March 31, 2023 | -180.54M |
| December 31, 2022 | -181.12M |
| September 30, 2022 | -181.49M |
| June 30, 2022 | -175.74M |
| March 31, 2022 | -166.13M |
| December 31, 2021 | -69.61M |
| September 30, 2021 | -61.64M |
| June 30, 2021 | -60.35M |
| March 31, 2021 | -56.08M |
| December 31, 2020 | -134.00M |
| Date | Value |
|---|---|
| September 30, 2020 | -132.06M |
| June 30, 2020 | -134.24M |
| March 31, 2020 | -145.92M |
| December 31, 2019 | -140.73M |
| September 30, 2019 | -133.28M |
| June 30, 2019 | -114.96M |
| March 31, 2019 | -86.58M |
| December 31, 2018 | -74.06M |
| September 30, 2018 | -59.18M |
| June 30, 2018 | -52.92M |
| March 31, 2018 | -46.52M |
| December 31, 2017 | -37.58M |
| September 30, 2017 | -34.15M |
| June 30, 2017 | -29.25M |
| March 31, 2017 | -27.43M |
| September 30, 2016 | -26.65M |
| June 30, 2016 | -22.58M |
| March 31, 2016 | -16.82M |
| December 31, 2015 | -10.88M |
| September 30, 2015 | -7.563M |
| December 31, 2014 | -7.976M |
| September 30, 2014 | -13.56M |
| June 30, 2014 | -17.79M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (TTM) Benchmarks
| ACADIA Pharmaceuticals, Inc. | 380.48M |
| Alnylam Pharmaceuticals, Inc. | 807.99M |
| BioMarin Pharmaceutical, Inc. | 72.97M |
| Cytokinetics, Inc. | -894.00M |
| Exelixis, Inc. | 860.62M |